Comparison of the Effectiveness of 2 Manual Therapies on Functional Outcome in Sub-acute and Chronic Non-specific Low Back Pain (LC OSTEO)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02034864 |
Recruitment Status :
Completed
First Posted : January 14, 2014
Last Update Posted : January 23, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Subacute and Chronic Non-specific Low Back Pain | Other: Osteopathic manipulative treatment Other: Placebo of osteopathic manipulative treatment | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 400 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Participant) |
Primary Purpose: | Treatment |
Official Title: | Comparison of the Effectiveness of 2 Manual Therapies on Functional Outcome in Sub-acute and Chronic Non-specific Low Back Pain at 3 Months : a Randomised Controlled Trial |
Actual Study Start Date : | February 17, 2014 |
Actual Primary Completion Date : | October 23, 2017 |
Actual Study Completion Date : | October 23, 2017 |

Arm | Intervention/treatment |
---|---|
Experimental: Osteopathic manipulative treatment
6 sessions of standardized manipulative treatment
|
Other: Osteopathic manipulative treatment
A standardized manipulative treatment according to the results of a physical examination including 7 anatomical areas will be given by trained osteopaths during 6 sessions (with an interval of 2 weeks between 2 sessions). Each session will last 45 minutes. Osteopaths will have 3 days of training in standardized manipulative treatment. |
Sham Comparator: Placebo of osteopathic manipulative treatment
6 sessions of standardized placebo of manipulative treatment
|
Other: Placebo of osteopathic manipulative treatment
A standardized placebo of manipulative treatment consisting in "light touch" and according to the results of a physical examination including 7 anatomical areas will be given by trained osteopaths during 6 sessions (with an interval of 2 weeks between 2 sessions). Each session will last 45 minutes. Osteopaths will have 3 days of training in standardized placebo of manipulative treatment. |
- Mean improvement from baseline in mean activity limitation [ Time Frame: 3 months after randomization ]Assessed with the self-administered Quebec functional scale (from 0, no limitation to 100, maximal limitation)
- Mean reduction from baseline in mean lumbar pain in the previous 48 hrs [ Time Frame: 3 months after randomization ]assessed with a self-administered 11-class numeric scale (from 0 no pain to 100, maximal pain)
- Mean reduction from baseline in mean lumbar pain in the previous 48 hrs [ Time Frame: 12 months after randomization ]assessed with a self-administered 11-class numeric scale (from 0, no pain to 100, maximal pain)
- Number of sick leaves [ Time Frame: 12 months after randomization ]self-reported number of sick leaves
- Duration of sick leaves [ Time Frame: 12 months after randomization ]self-reported total duration (days) of sick leaves
- Recurrence of pain [ Time Frame: 12 months after randomization ]self-reported number of low back pain episodes
- Mean improvement from baseline in mean activity limitation [ Time Frame: 12 months after randomization ]Assessed with the self-administered Quebec functional scale (from 0, no limitation to 100, maximal limitation)
- Mean improvement from baseline in mean quality of life [ Time Frame: 3 months after randomization ]Assessed with the physical and mental components of the self-administered MOS SF-12 questionnaire (from 0, worse quality of life to 100, best quality of life)
- Mean improvement from baseline in mean quality of life [ Time Frame: 12 months after randomization ]Assessed with the physical and mental components of the self-administered MOS SF-12 questionnaire (from 0, worse quality of life to 100, best quality of life)
- Pain killer and non-steroidal anti-inflammatory drug consumption [ Time Frame: 3 months after randomization ]self-reported consumption of pain killer and non-steroidal anti-inflammatory drugs since last contact ( yes/no)
- Pain killer and non-steroidal anti-inflammatory drug consumption [ Time Frame: 12 months after randomization ]self-reported consumption of pain killer and non-steroidal anti-inflammatory drugs since last contact ( yes/no)

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patient consulting for subacute and chronic non-specific low
- Male or female aged from 18 to 65 years (included)
- Patient can speak and understand French
- Patient giving his informed consent to participate in the study
- Patient affiliated to or beneficiary of social insurance
Exclusion Criteria:
- Specific low-back pain caused by inflammatory, tumoral, infectious disease or a back traumatism in the 3 past months
- History of back surgery and/or vertebral fracture in the previous 6 months
- Presence of a motor impairment related to the reason for consultation
- The patient is a student or a practitioner in manipulative therapies
- Pregnancy
- Inability to understand the process of the study
- The patient is already included in another clinical study

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02034864
France | |
CHU Cochin | |
Paris, France, 75014 |
Principal Investigator: | Francois Rannou, MD PhD | AP-HP, Descartes University, INSERM |
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Assistance Publique - Hôpitaux de Paris |
ClinicalTrials.gov Identifier: | NCT02034864 |
Other Study ID Numbers: |
P110142 |
First Posted: | January 14, 2014 Key Record Dates |
Last Update Posted: | January 23, 2019 |
Last Verified: | January 2019 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
low back pain manual therapy randomized controlled trial |
Back Pain Low Back Pain Pain Neurologic Manifestations |